HOMECONTACTSITE MAPSEARCH

Stock Information
NASDAQ:INFI
$6.18   - 0.03
Feb 8, 2010
3:59 PM ET
Quotes delayed at least 20 minutes. Data provided by eSignal.
Press Releases

= Add Release to Briefcase

Feb 3, 2010 Infinity Announces 2009 Financial Results Conference Call PDF Add to Briefcase
Jan 11, 2010 Infinity Announces Key 2010 Objectives PDF Add to Briefcase
Jan 11, 2010 Infinity Announces Updated Presentation Time at the J.P. Morgan Healthcare Conference PDF Add to Briefcase
Jan 7, 2010 Infinity Announces Presentations at January Conferences PDF Add to Briefcase
Dec 7, 2009 Infinity Names Adelene Q. Perkins Chief Executive Officer PDF Add to Briefcase
Nov 17, 2009 Infinity's IPI-504 Named One of Windhover and Campbell Alliance's "Top 10 Projects to Watch" in Oncology PDF Add to Briefcase
Nov 16, 2009 Adelene Q. Perkins Named "Best Executive" at Annual Stevie(R) Awards Ceremony PDF Add to Briefcase
Nov 10, 2009 Infinity to Present at Upcoming Conferences PDF Add to Briefcase
Nov 9, 2009 Infinity Reports Recent R&D Highlights and Third Quarter 2009 Results PDF Add to Briefcase
Nov 2, 2009 Infinity Announces Third Quarter 2009 Results Conference Call PDF Add to Briefcase
Oct 7, 2009 Infinity Announces Appointment of Dr. Thomas J. Lynch to Its Board of Directors PDF Add to Briefcase
Sep 2, 2009 Infinity to Present At Upcoming Conferences PDF Add to Briefcase
Aug 5, 2009 Infinity Reports Recent R&D Highlights and Second Quarter 2009 Results PDF Add to Briefcase
Jul 30, 2009 Infinity Announces Second Quarter 2009 Results Conference Call PDF Add to Briefcase
Jul 23, 2009 Infinity Paper On Discovery of Its Novel Hedgehog Inhibitor, IPI-926, Published in Journal of Medicinal Chemistry PDF Add to Briefcase
Jun 29, 2009 Infinity Pharmaceuticals Added to Russell 2000(r) Index PDF Add to Briefcase
May 30, 2009 Infinity Reports Encouraging Clinical Data for IPI-504 at ASCO 2009 PDF Add to Briefcase
May 29, 2009 New Paper in Science Features Infinity's IPI-926 Hedgehog Pathway Inhibitor as a Promising New Approach in Chemo-Resistant Pancreatic Cancer PDF Add to Briefcase
May 27, 2009 Infinity Pharmaceuticals Named Winner of The Scientist's 'Best Places to Work in Industry' and Featured in Boston Business Journal's Best Places to Work 2009 Survey PDF Add to Briefcase
May 13, 2009 Clinical Data From Infinity's Hsp90 Chaperone Inhibitor Program to be Presented During ASCO Meeting PDF Add to Briefcase
Showing 1-20 of 132 releases Page: 1 2 3 4 5 6 7  See Next 20

For historical Infinity Pharmaceuticals announcements, please contact Monique Allaire.

Request Investor Kit
Shareholder Briefcase
Receive Email Alerts
Subscribe to News
Search
© 2001-2010 Infinity Pharmaceuticals, Inc. All rights reserved. | Terms | Forward Looking Statements | Privacy